Skip to search.
 FTSE 100 Down 0.39%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
8.36 Up 0.19(2.29%) 14:33
Add to Portfolio
Prev Close:8.18
Open:8.12
Bid:8.15
Ask:8.40
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:8.12 - 8.39
52wk Range:1.77 - 10.13
Volume:1,764,976
Avg Vol (3m):5,048,990
Market Cap:208.60m
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,552.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines for the treatment of cancer, and age-related or inherited neurodegenerative disorders and ocular diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback